Apica Creates Game-Changer for Valve Implant Procedures

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Apica Cardiovascular, a company based in Galway, Ireland, has developed an innovative platform that will help change the game for valve implant procedures requiring transapical access, such as TAVI (transcatheter aortic valve implantation). Using the apex of the heart as the entry point, the Access, Stabilization, and Closure (ASC) system allows surgeons to implant prosthetic aortic and mitral valves, all while the heart continues to beat. Upon a successful implantation, the system standardizes closure by quickly stabilizing and sealing the tissue of the access point without conventional sutures, minimizing blood loss and the chance for an air embolism.

Hey, check out all the engineering jobs. Post your resume today!